Caspofungin in combination with amphotericin B against Candida glabrata

被引：23

作者：

Barchiesi, F

Spreghini, E

Fothergill, AW

Arzeni, D

Greganti, G

Giannini, D

Rinaldi, MG

Scalise, G

机构：

[1] Univ Politecn Marche, Ist Malattie Infett & Med Pubbl, Ancona, Italy

[2] Univ Politecn Marche, Ctr Gestione Presidenza Med & Chirurg, Ancona, Italy

[3] Univ Texas, Hlth Sci Ctr, Dept Pathol, San Antonio, TX 78284 USA

[4] S Texas Vet Hlth Care Syst, Audie Murphy Div, San Antonio, TX USA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2005年 / 49卷 / 06期

关键词：

D O I：

10.1128/AAC.49.6.2546-2549.2005

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The effects of caspofungin combined with amphotericin B were investigated with Candida glabrata. Although in vitro experiments showed an indifferent interaction, the combination regimen was the only therapeutic approach yielding organ sterilization in a murine candidemia model.

引用

收藏

页码：2546 / 2549

页数：4

相关论文

共 9 条

[1]

Deresinski SC, 2003, CLIN INFECT DIS, V36, P1445, DOI 10.1086/375080

[2] Nosocomial bloodstream infections in United States hospitals: A three-year analysis [J].

Edmond, MB ;

Wallace, SE ;

McClish, DK ;

Pfaller, MA ;

Jones, RN ;

Wenzel, RP .

CLINICAL INFECTIOUS DISEASES, 1999, 29 (02) :239-244

[3] Candida glabrata:: Review of epidemiology, pathogenesis, and clinical disease with comparison to C-albicans [J].

Fidel, PL ;

Vazquez, JA ;

Sobel, JD .

CLINICAL MICROBIOLOGY REVIEWS, 1999, 12 (01) :80-+

[4] Efficacy of caspofungin combined with amphotericin B against azole-resistant Candida albicans [J].

Hossain, MA ;

Reyes, GH ;

Long, LA ;

Mukherjee, PK ;

Ghannoum, MA .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (06) :1427-1429

[5] Combination antifungal therapy [J].

Johnson, MD ;

MacDougall, C ;

Ostrosky-Zeichner, L ;

Perfect, JR ;

Rex, JH .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (03) :693-715

[6]

National Committee for Clinical Laboratory Standards, 2002, M27A2 NAT COMM CLIN

[7] Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents:: A global assessment from the ARTEMIS antifungal surveillance program conducted in 2001 and 2002 [J].

Pfaller, MA ;

Messer, SA ;

Boyken, L ;

Tendolkar, S ;

Hollis, RJ ;

Diekema, DJ .

JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (07) :3142-3146

[8] Determination of fungicidal activities against yeasts and molds: Lessons learned from bactericidal testing and the need for standardization [J].

Pfaller, MA ;

Sheehan, DJ ;

Rex, JH .

CLINICAL MICROBIOLOGY REVIEWS, 2004, 17 (02) :268-+

[9] Candidemia in cancer patients: A prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC) [J].

Viscoli, C ;

Girmenia, C ;

Marinus, A ;

Collette, L ;

Martino, P ;

Vandercam, B ;

Doyen, C ;

Lebeau, B ;

Spence, D ;

Krcmery, V ;

De Pauw, B ;

Meunier, F .

CLINICAL INFECTIOUS DISEASES, 1999, 28 (05) :1071-1079